Public Company News
Clarity signs copper-67 Supply Agreement with Nusano
SYDNEY, Oct. 16, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce the signing of a Supp...
2025-10-16 21:04
2900
Hyundai Mobis wins awards at three global advertising festivals with 'Move Improved' campaign
* Selected as a finalist in the 'Corporate Online Media – Social Media Videos' category at the 16th Cannes Corporate Media & TV Awards... the only Korean company in the list * Also won top prizes at North American global advertising festivals '2025 Muse Creative Award' and '2025 NYX Award' ...
2025-10-16 20:00
2207
Canadian Solar Schedules Third Quarter 2025 Earnings Conference Call for November 13
KITCHENER, ON, Oct. 16, 2025 /PRNewswire/ -- Canadian Solar Inc
2025-10-16 19:00
1411
HD Hyundai Electric Accelerates Expansion into the North American Low- and Medium-Voltage Circuit Breaker Market with UL Certification
* Secures UL and cUL certifications for four types of low- and medium-voltage circuit breakers, reinforcing competitiveness inNorth America * Global low- and medium-voltage circuit breaker market projected to reach USD 29.2 billion by 2034, growing at a CAGR of 8.8% * "The company plans to e...
2025-10-16 12:28
1148
HARMONi-6 Phase III Study of Ivonescimab Accepted by The Lancet and Selected for ESMO 2025 LBA Presentation
HONG KONG, Oct. 16, 2025 /PRNewswire/ -- Akeso Inc. (9926.HK) today announced that the groundbreaking results from the registrational Phase III AK112-306/HARMONi-6 study of ivonescimab have been accepted for publication in The Lancet. The study evaluated ivonescimab, a first-in-class PD-1/VEGF b...
2025-10-16 12:15
1529
Jacobio Pharma Announces Strategic Partnership with Oceanpine Capital to Focus on Core Oncology Pipeline
BEIJING and SHANGHAI and BOSTON, Oct. 15, 2025 /PRNewswire/ -- Jacobio Pharma (1167.HK) today announced that its subsidiary, Beijing Jacobio Pharmaceuticals Co., Ltd. ("Beijing Jacobio"), has entered into a Capital Increase and Equity Transfer Agreement with Oceanpine Capital and an industry part...
2025-10-15 23:05
2617
Fibocom Unveils Cutting-Edge 5G FWA Portfolio Featuring MediaTek T930 at NetworkX 2025
PARIS, Oct. 15, 2025 /PRNewswire/ -- Fibocom, a leading global provider of wireless communication modules and AI solutions, introduced its new series of 5G FWA solutions powered by the MediaTek T930 platform. The lineup includes the FG390-NA module, featuring advanced RF integration and full comp...
2025-10-15 23:04
1950
CJ BIO Showcases Science-Backed Nutrition Solutions at SSG 2025
DOWNERS GROVE, Ill., Oct. 15, 2025 /PRNewswire/ -- CJ BIO, a global leader in functional health and nutrition solutions, will join SupplySide Global 2025 under the theme "Where Function Meets Clinical Proof." The company will present science-backed Nutrition Solutions for muscle health, beauty, a...
2025-10-15 22:00
1586
Extend full-chain guarantee mechanism globally: EPWK builds a bridge of trust for cross-border creative transactions
XIAME, China, Oct. 15, 2025 /PRNewswire/ -- Recently, EPWK International (intl.epwk.com) has officially launched its operations, attracting thousands of users from across the globe to register daily. Successful internationalization will help EPWK completely transform from a local Chinese company ...
2025-10-15 20:00
1385
SK bioscience Files for First-in-Human Trial of Universal Coronavirus Vaccine (Pan-sarbecovirus Vaccine) GBP511 Phase 1/2 study in Australia
* Candidate designed to protect against COVID-19 variants and broader Sarbecoviruses * Phase 1/2 study to enroll ~500 healthy adults, with topline results expected by 2028 * We aim to build a universal Sarbecovirus vaccine platform to proactively address future pandemics SEONGNAM, South Kor...
2025-10-15 20:00
2268
Cango Inc. to Terminate ADR Program and List Class A Ordinary Shares Directly on NYSE
HONG KONG, Oct. 15, 2025 /PRNewswire/ -- Cango Inc. (NYSE: CANG) ("Cango" or the "Company") today announced that its board of directors has approved the termination of its American depository receipt ("ADR") program*. The ADR program and the related Deposit Agreement are expected to terminate aft...
2025-10-15 18:00
1679
Yum China to Report Third Quarter 2025 Financial Results
SHANGHAI, Oct. 15, 2025 /PRNewswire/ -- Yum China Holdings, Inc. (NYSE: YUMC and HKEX: 9987, "Yum China" or the "Company") today announced that it will report its unaudited financial results for the third quarter endedSeptember 30, 2025 before the U.S. market opens on Tuesday, November 4, 2025 (a...
2025-10-15 17:00
1742
Recon Technology, Ltd Reports Financial Year Results for Fiscal Year 2025
BEIJING, Oct. 14, 2025 /PRNewswire/ -- Recon Technology, Ltd (NASDAQ: RCON) ("Recon" or the "Company"), aChina-based independent solutions integrator in the oilfield service and environmental protection, electric power and coal chemical industries, today announced its financial results for fiscal...
2025-10-15 04:30
2143
Alcor Micro to Showcase Latest Arm-based CPU Platform "Mobius100 (CSS V3)" at OCP Global Summit 2025
SAN JOSE, Calif., Oct. 14, 2025 /PRNewswire/ -- Alcor Micro (8054.TWO), a subsidiary of Egis Technology Inc. (6462.TWO), will participate in the Open Compute Project (OCP) Global Summit 2025 held inSan Jose, California, to showcase its latest Arm-based CPU platform — Mobius100 (CSS V3). The 8-cor...
2025-10-15 01:00
5047
Mabwell Announces Latest Clinical Results of Novel B7-H3-Targeting ADC 7MW3711 to Be Presented at 2025 ESMO Congress
SHANGHAI, Oct. 14, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that clinical research results of its novel B7-H3-targeting ADC (R&D code: 7MW3711) for multiple advanced solid tumors, will be presented as a poster at the E...
2025-10-15 00:00
2785
Co-PSMA trial achieves primary endpoint
SYDNEY, Oct. 14, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce that the Co-PSMA (NCT...
2025-10-14 21:03
2822
Lunit AI Predicts Immunotherapy Outcome in Colorectal, Kidney, and Lung Cancer at ESMO 2025
AI-powered histopathology demonstrates predictive value for immunotherapy outcomes in pMMR mCRC, advanced ccRCC, and NSCLC with data featured in both oral and poster presentations SEOUL, South Korea, Oct. 14, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnos...
2025-10-14 21:00
1182
TOYO's Houston Solar Module Facility Commences Commercial Operations with Secured Customer Demands
TOKYO, Oct. 14, 2025 /PRNewswire/ -- TOYO Co., Ltd
2025-10-14 20:30
1790
Daesang Successfully Participates in 'ANUGA 2025,' Secures Foothold for European Expansion
* Promoted K-Food through Jongga and O'food at the world's largest food trade fair, which drew around 160,000 visitors fromOctober 4 to 8 * Up to 3,000 visitors per day stopped by the booth during the five-day event, with three fusion dishes featuring Jongga Kimchi earning rave reviews. SEOUL...
2025-10-14 20:00
1690
Mabwell's CDH17-targeting ADC 7MW4911 Receives IND Clearance from NMPA
SHANGHAI, Oct. 14, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its self-developed CDH17-targeting ADC (R&D code: 7MW4911) received IND clearance from the National Medical Products Administration (NMPA) inChina to ini...
2025-10-14 20:00
1978
Week's Top Stories
Most Reposted
HBX Group and Traveloka expand strategic partnership to deepen APAC supply and accelerate global distribution
[Picked up by 310 media titles]
2026-02-26 09:30
Amadeus acquires SkyLink to accelerate the deployment of AI in travel
[Picked up by 308 media titles]
2026-02-26 19:57
Visa partners with Laufey to spread the magic of travel in Asia Pacific; to be Official Payment Partner for Laufey: A Matter of Time Tour
[Picked up by 304 media titles]
2026-03-04 12:35
SMU and Fudan Launch Region's First Tech-Focused DBA
[Picked up by 300 media titles]
2026-03-02 09:15Infobip is set to launch AgentOS to orchestrate autonomous AI-driven customer journeys at scale
[Picked up by 289 media titles]
2026-03-02 09:00
Most Read
COLUMBIA ASIA HOSPITAL BUKIT JALIL LAUNCHES NEW CATH LAB TO STRENGTHEN HEART CARE SERVICES
2026-03-02 14:24
8752
